
White Raven
Sitio de fill & finish dedicado a la formulación GMP y al llenado aséptico de inyectables líquidos estériles.
MERCATI: EMA (EU)
REGIONE: Europe
CATEGORIA / PRODOTTO: FDF / PRODOTTI FARMACEUTICI, CHIMICO-SINTETICO, SERVIZI
USO: Umano
BSL (Livello di sicurezza biologica): 1, 2
SERVIZI: Manufacturing services, Packaging
DIMENSIONE DEL LOTTO: Piccolo, Medio
COMPLIANCE: EMA (GMP UE)

Viswa Laboratories Private Limited
CRAMS/CDMO, API, Productos intermedios y especialidades químicas
MERCATI: EMA (EU), NMPA (China), ANVISA (Brazil), Russian Health Authorities, CDSCO (India)
REGIONE: APAC, Europe
DIMENSIONE DEL LOTTO: Grande, Piccolo, Medio
CATEGORIA / PRODOTTO: CHIMICO-SINTETICO, SERVIZI
USO: Umano, Veterinario
BSL (Livello di sicurezza biologica): 2
SERVIZI: Development services, Manufacturing services, Regulatory services
AREE TERAPEUTICHE DI COMPETENZA (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (R) Respiratory system
SOSTANZE CONTROLLATE: Lower potential for abuse
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1.000 µg/giorno)
COMPLIANCE: Organizzazione Mondiale della Sanità (GMP / HACCP)
COMPLIANCE: ICH, FDA (cGMP), ISO, EMA (GMP UE), Organizzazione Mondiale della Sanità (GMP / HACCP)
MERCATI: EMA (EU), FDA (USA)
SERVIZI: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services
REGIONE: Europe
DIMENSIONE DEL LOTTO: Grande, Piccolo, Medio
CATEGORIA / PRODOTTO: CHIMICO-SINTETICO, OLIGONUCLEOTIDI, SERVIZI
USO: Umano, Veterinario
AREE TERAPEUTICHE DI COMPETENZA (ATC): (L) Antineoplastic and immunomodulating agents
OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1.000 - 5.000 µg/giorno), 3 (PDE = 100 - 1.000 µg/giorno)

Sidefarma SA
Sidefarma es un CMO especializado en la fabricación de lotes peque os y medianos para compa ías farmacéuticas de todo el mundo, en mercados regulados y siguiend
SOSTANZE CONTROLLATE: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
MERCATI: EMA (EU), PMDA (Japan), Health Canada (Canada), DIGEMID (Peru), MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities, EDE (UAE), TGA (Australia)
REGIONE: Europe
COMPLIANCE: ISO, UAE Ministry of Health & Prevention, EMA (GMP UE)
CATEGORIA / PRODOTTO: FDF / PRODOTTI FARMACEUTICI, CHIMICO-SINTETICO, SERVIZI
USO: Umano
SERVIZI: Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1.000 - 5.000 µg/giorno), 3 (PDE = 100 - 1.000 µg/giorno)
DIMENSIONE DEL LOTTO: Piccolo, Medio

Rodon Biologics - RDN Serviços de Biotecnologia
Rodon Biologics ofrece excelencia en el desarrollo de productos biofarmacéuticos para terceros.
REGIONE: Europe
CATEGORIA / PRODOTTO: FDF / PRODOTTI FARMACEUTICI, CHIMICO-SINTETICO, NUTRACEUTICI, OLIGONUCLEOTIDI, BIOLOGIA, SERVIZI
USO: Umano
BSL (Livello di sicurezza biologica): 1, 2
SERVIZI: Development services, Manufacturing services, Analytical / QC services
AREE TERAPEUTICHE DI COMPETENZA (ATC): (L) Antineoplastic and immunomodulating agents
DIMENSIONE DEL LOTTO: Piccolo
MERCATI: EMA (EU), NMPA (China), FDA (USA), Health Canada (Canada), MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE)
REGIONE: Europe
COMPLIANCE: FDA (cGMP), IFS, Consiglio di ricerca halal, UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority), EMA (GMP UE), Organizzazione Mondiale della Sanità (GMP / HACCP), NSF
CATEGORIA / PRODOTTO: FDF / PRODOTTI FARMACEUTICI, CHIMICO-SINTETICO, NUTRACEUTICI, SERVIZI
USO: Umano, Veterinario
SERVIZI: Development services, Manufacturing services
AREE TERAPEUTICHE DI COMPETENZA (ATC): (V06) Nutrients
DIMENSIONE DEL LOTTO: Medio

Pharmaron
Instalación comercial de moléculas peque as (RSM/API)
AREE TERAPEUTICHE DI COMPETENZA (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
SOSTANZE CONTROLLATE: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse
MERCATI: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), MHRA (UK), MFDS (South Korea), TGA (Australia)
SERVIZI: Logistics, Development services, Manufacturing services
COMPLIANCE: FDA (cGMP), ISO, ECOVADIS
DIMENSIONE DEL LOTTO: Grande, Piccolo, Medio
CATEGORIA / PRODOTTO: CHIMICO-SINTETICO, SERVIZI
USO: Umano, Veterinario
OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1.000 - 5.000 µg/giorno), 3 (PDE = 100 - 1.000 µg/giorno)
REGIONE: North America

Pharmaron
Instalación comercial de moléculas peque as (RSM/API) / péptidos
AREE TERAPEUTICHE DI COMPETENZA (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (V09-10) Radiopharmaceuticals, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1.000 - 5.000 µg/giorno), 3 (PDE = 100 - 1.000 µg/giorno)
MERCATI: NMPA (China), FDA (USA)
REGIONE: APAC
COMPLIANCE: FDA (cGMP), ISO, NMPA (Cina GMP)
DIMENSIONE DEL LOTTO: Grande, Piccolo, Medio
CATEGORIA / PRODOTTO: CHIMICO-SINTETICO, INGEGNERIA DELLE PARTICELLE
USO: Umano, Veterinario
SERVIZI: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

Pharmaron
Instalación comercial de moléculas peque as (RSM/API)
AREE TERAPEUTICHE DI COMPETENZA (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
SOSTANZE CONTROLLATE: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse
MERCATI: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)
SERVIZI: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services
REGIONE: Europe
COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), EMA (GMP UE), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Repubblica di Corea GMP)
DIMENSIONE DEL LOTTO: Grande, Piccolo, Medio
CATEGORIA / PRODOTTO: CHIMICO-SINTETICO
USO: Umano, Veterinario
OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1.000 - 5.000 µg/giorno), 3 (PDE = 100 - 1.000 µg/giorno)

Indena
Nuestra instalación totalmente conforme con GMP y aprobada por la FDA, ubicada en Settala (a 20 minutos de Milán), está especializada en APIs complejos y compue
OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1.000 - 5.000 µg/giorno), 3 (PDE = 100 - 1.000 µg/giorno)
MERCATI: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia)
SERVIZI: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
REGIONE: Europe
COMPLIANCE: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), NMPA (Cina GMP), EMA (GMP UE), MFDS/KFDA (Repubblica di Corea GMP)
DIMENSIONE DEL LOTTO: Grande, Piccolo, Medio
CATEGORIA / PRODOTTO: CHIMICO-SINTETICO, SERVIZI
USO: Umano, Veterinario

Hikal Ltd.
Desarrollo de procesos cGMP, escalado y fabricación de APIs de moléculas pequeñas, nuevas entidades moleculares (NMEs) e intermedios, desde gramos hasta kilogra
COMPLIANCE: ANVISA (Brazil B-GMP), COFEPRIS, Consiglio di ricerca halal, ECOVADIS, TGA (Australia GMP), FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), EMA (GMP UE)
OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/giorno), 5 / HPAPI (PDE < 10 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1.000 - 5.000 µg/giorno), 3 (PDE = 100 - 1.000 µg/giorno)
MERCATI: ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), TGA (Australia)
REGIONE: APAC
DIMENSIONE DEL LOTTO: Grande, Piccolo, Medio
CATEGORIA / PRODOTTO: CHIMICO-SINTETICO, COSMETICI, NUTRACEUTICI, SERVIZI
USO: Umano, Veterinario
SERVIZI: Development services, Manufacturing services, Regulatory services
AREE TERAPEUTICHE DI COMPETENZA (ATC): (C) Cardiovascular system, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (V06) Nutrients

HIPRA Biotech Services
Capacidades internas de principio a fin, desde el desarrollo de líneas celulares hasta la fabricación comercial.
MERCATI: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)
SERVIZI: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
REGIONE: Europe
COMPLIANCE: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (nuove BPF dell'Argentina), EMA (GMP UE), Health Canada (Canada GMP), Organizzazione Mondiale della Sanità (GMP / HACCP), MHRA (UK GMP)
DIMENSIONE DEL LOTTO: Grande, Piccolo, Medio
CATEGORIA / PRODOTTO: CHIMICO-SINTETICO, OLIGONUCLEOTIDI, BIOLOGIA, SERVIZI
USO: Umano, Veterinario
BSL (Livello di sicurezza biologica): 1, 2
AREE TERAPEUTICHE DI COMPETENZA (ATC): (L) Antineoplastic and immunomodulating agents
OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1.000 - 5.000 µg/giorno), 3 (PDE = 100 - 1.000 µg/giorno)
Register to unlock the full catalog with contact details and locations.
+81 more facilities
Create free account